Entheon Biomedical
Pharmaceutical ManufacturingView the employees at
Entheon Biomedical-
Timothy Ko CEO at Entheon Biomedical
-
Canada
-
Rising Star
Soo-Whan Kim Chief Financial Officer-
Toronto, Ontario, Canada
-
Top 10%
-
Overview
When it comes to treating addiction, the rate of success is so low that society has been conditioned to accept – and even expect – failure. This manner of thinking is both unacceptable and counterproductive. There is a need for an alternative approach, that addresses the human cost of addiction for individuals, families and society at large. We are developing a DMT-assisted therapeutic protocol that will be specifically tailored to address the core mechanisms underlying drug-seeking and using behavior. Our chief aim is to provide an effective and scalable therapeutic protocol that will serve as a vital resource for those afflicted with a substance-use disorder, and who are wanting to reclaim their lives.